Effect of β-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: Data from a large HMO

American Heart Journal

Volumn 134, Issue 4, 1997, Pages 608-613

  Barron, H V ^a   Viskin, S ^a   Lundstrom, R J ^a   Wong, C C ^a   Swain, B E ^a   Truman, A F ^a   Selby, J V ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPYRIDAMOLE; DIURETIC AGENT; DOBUTAMINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SURVIVAL;

EID: 0030722906     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(97)70042-5     Document Type: Article

References (14)

1. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group Eur Heart J 9 1988 8 16
2. S Yusuf R Peto J Lewis R Collins P. Sleight Beta blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 1985 335 371
3. S Yusuf P Sleight P Held S. McMahon Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials Circulation 82 II 1990 117 1134
4. WH Frishman CD Furberg WT. Friedewald Beta-adrenergic blockade for survivors of acute myocardial infarction N Engl J Med 310 1984 830 837
5. MJ Kendall KP Lynch A Hjalmarson J. Kjekshus Beta-blockers and sudden cardiac death Ann Intern Med 123 1995 358 367
6. S Viskin I Kitzis E Lev Z Zak K Heller Y Villa Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice J Am Coll Cardiol 25 1995 1327 1332
7. HL Kennedy RS. Rosenson Physician use of beta-adrenergic blocking therapy: a changing perspective [editorial] J Am Coll Cardiol 26 1995 547 552
8. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators N Engl J Med 329 1993 673 682
9. RM Gunnar PD Bourdillon DW Dixon V Fuster RB Karp JW Kennedy ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction) Circulation 82 1990 664 707
10. JV Selby BH Fireman RJ Lundstrom BE Swain AF Truman CC Wong Geographic variation in coronary revascularization practices and outcomes after myocardial infarction in a large health maintenance organization N Engl J Med 335 1996 1888 1896
11. ME Charlson P Pompei KL Ales CR. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
12. S. Yusuf An overview of the clinical trials of agents (other than beta-blockers) that potentially limit myocardial infarct size J Cardiovasc Pharmacol 12 Suppl 1 1988 S48 S55
13. The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group N Engl J Med 319 1988 385 392
14. AE Arnold ML Simoons F Van de Werf DP de Bono J Lubsen JG Tijssen Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group Circulation 86 1992 111 120